PRKCD and glioblastoma: Utilizing two strategies—microglia-specific AAV-mediated PRKCD overexpression and systemic niacin administration—we demonstrate that PKCδ upregulation significantly enhances both phagocytosis of BTICs and induction of BTIC apoptosis, translating into survival benefits in a murine GBM model.